Intelligence · Clinical Development
Pipeline search results
Programs matching “powder” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 47 pipeline programs matching "powder" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Abraxane /ml powder for dispersion for infusion. for metastatic NSCLC patients
Fondazione Telethon ETS
metastatic NSCLC patients
1 trial -
Ciprofloxacin (BAYQ3939) dry powder for inhalation
Bayer HealthCare AG
Bronchiectasis
1 trial -
FF/GW642444 Inhalation Powder
GlaxoSmithKline
Pulmonary Disease, Chronic Obstructive
2 trials -
Fluticasone Propionate and Salmeterol Inhalation Powder
Teva Pharma GmbH
Asthma
1 trial -
Human Insulin Inhalation Powder
Eli Lilly and Company
Diabetes Mellitus
1 trial -
Idefirix 11 mg powder for concentrate for solution for infusion
Hansa Biopharma AB
End stage chronic kidney disease (CKD) patients who are highly sensitised and on the kidney transplant list awaiting a kidney transplant
1 trial -
Kyprolis powder for relapsed/refractory multiple my…
Disc Medicine
relapsed/refractory multiple myeloma
1 trial -
MINJUVI 200 mg powder for concentrate for solution for infusion
Incyte
Immune-mediated thrombocytopenia, Autoimmune thrombocytopenia, Autoimmune hemolytic anemia
1 trial -
Metalyse 5 000 units (25 mg) powder for solution for injection
Pari Pharma GmbH
Adult patients with a LVOS with large core within 9 hours of symptoms onset or last seen well, or with a diffusion weighted imaging (DWI)-fluid attenuated inversion recovery (FLAIR) mismatch in case of unknown onset.
1 trial -
Metalyse 5 000 units (25 mg) powder for solution for injection
Boehringer Ingelheim
Acute Ischemic Stroke
1 trial -
Powder for reconstitution for enteral administration
Lacuna Pharma Pty Ltd
Intestinal Malabsorption
1 trial -
Powder for reconstitution for enteral administration
Lacuna Pharma Pty Ltd
Intestinal Malabsorption
1 trial -
sotatercept, PL1 - Powder for injection
Lacuna Pharma Pty Ltd
Therapeutic confirmatory (phase III)
1 trial -
ADCETRIS 50 mg powder for concentrate for solution for infusion
Takeda
Hodgkin lymphoma (HL) - Hodgkin lymphoma (HL), a neoplasm of lymphoid tissue which is histopathologically defined by the presence of malignant Hodgkin Reed-Sternberg (HRS) cells in a background of inflammatory cells. The proposed pediatric study has been designed to evaluate brentuximab vedotin as a component of a multiagent frontline chemotherapy regimen in patients with advanced stage, newly diagnosed HL, here defined as Stage III and Stage IV and a ≥50 Lansky Play-Performance or Karnofsky Performance Status.
1 trial -
BOTOX 100 Allergan Units Powder for Solution for Injection
Disc Medicine
postoperative pancreatic fistulas
1 trial -
Byfavo 20 mg powder for solution for injection
Disc Medicine
stress anxiety, anxiety
1 trial -
Cinryze powder and solvent for solution for i... for Traumatic Brain Injury
Disc Medicine
Traumatic Brain Injury
1 trial -
Crofelemer Placebo Powder for Oral Solution
Lacuna Pharma Pty Ltd
Microvillous Inclusion Disease (MVID)
1 trial -
Entyvio 300 mg powder for concentrate for solution for infusion
Takeda
Ulcerative Colitis or Crohn's Disease
1 trial -
Gliolan 30 mg/ml powder for oral solution.
Photonamic GmbH & Co. KG
Colorectal Carcinoma
1 trial -
Gliolan 30 mg/ml powder for oral solution.
Photonamic GmbH & Co. KG
Glioblastoma
1 trial -
Idefirix 11 mg powder for concentrate for solution for infusion
Disc Medicine
neuromyelitis optica spectrum disorder, devic disease
1 trial -
Lanthanum Polystyrene Sulphonate Powder
The First People's Hospital of Lianyungang
Hyperphosphatemia
1 trial -
Mineral-enriched powder
Disc Medicine
Iron Deficiency
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.